Education
About Us
Working with TipRanks
Follow Us
Helen Susan Kim Insider Profile
4 Followers
Helen Susan Kim, EVP BD at Kite Pharma Inc, holds 9.20K shares in Kite Pharma Inc (Ticker: KITE), holds ― shares in Assembly Biosciences (Ticker: ASMB), holds ― shares in Exicure (Ticker: XCUR).
Helen Susan Kim Kite Pharma Inc (KITE)EVP BD
Kite Pharma Inc (KITE)
EVP BD
Not Ranked
Ranked #77,966 out of 105,518 Corporate Insiders
Helen Susan Kim has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Helen Susan Kim holds in companies
Most Profitable Insider Trade
Stock:
Applied Molecular Transport
(AMTI)
(AMTI)
Rating:Informative Sell
Date:Jul 06, 2021 - Jul 06, 2022
Return:+94.70%
The most profitable trade made by Helen Susan Kim
Helen Susan Kim's Trading History
Kite Pharma Inc
Oct 05, 2017
―
Uninformative Sell
754.74K
$1.65M
Assembly Biosciences
―
Director
―
―
Exicure
―
Director
―
―
Applied Molecular Transport
Aug 27, 2021
―
Uninformative Sell
453.50K
$151.22K
Prothena
―
Director
―
―
Aktis Oncology, Inc.
Jan 12, 2026
Director, Ten Percent Owner
Uninformative Buy
―
$3.36M
Viracta Therapeutics
―
―
―
$0.00
ImmunoCellular Therapeutics
May 25, 2012
Director
Uninformative Buy
―
$300.06
List of latest transactions for each holding click on a transaction to see Helen Susan Kim's performance on stock
You May Also Like
Helen Susan Kim insider profile FAQ
What is the percentage of profitable transactions made by Helen Susan Kim?
The percentage of profitable transactions made by Helen Susan Kim is ―.
What is the average return per transaction made by Helen Susan Kim?
The average return per transaction made by Helen Susan Kim is ―.
What stocks does Helen Susan Kim hold?
Helen Susan Kim holds: KITE, ASMB, XCUR, AMTI, PRTA, AKTS, VIRX, IMUC stocks.
What was Helen Susan Kim’s latest transaction?
Helen Susan Kim latest transaction was an Uninformative Sell of $754.74K.
What was Helen Susan Kim's most profitable transaction?
Helen Susan Kim’s most profitable transaction was an Informative Sell of AMTI stock on July 6, 2021. The return on the trade was 94.70%.
What is Helen Susan Kim's role in Kite Pharma Inc?
Helen Susan Kim's role in Kite Pharma Inc is EVP BD.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.